RE:Is the Therapix Deal good for FSDI think the deal is very good for HUGE. If they want to be a major player in medical they need to do somethign to move in that direction. An idependent analysit valued TRPX at 84 million US, so getting an asset like that with a stock only transaction shoudl add value to HUGE.
Who knows what it will mean for SP in the short term, that is anyones guess, but it makes HUGE a much more legit company in the medical research space.
HUGE is in a great position to cover the expenses of continuing the research since they have no cost for the build out has that is being covered by XLY. Should only be 1-1.5 years for FDA approvals and selling, assuming trials go well.
If HUGE does not buy TRPX then they are going to go shopping and likely issue shares to buy another company instead so share dilustion is going to happen regardless.